Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging

References

• ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, et al. 2009. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373:137–146.
   PubMed Web of Science ®Google Scholar
• Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, et al. 2017. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: results from the FRANCOGYN study group. Gynecologic Oncology 144:107–112.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. 2013. Integrated genomic characterization of endometrial carcinoma. Nature 497:67–73.
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. 2016. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. International Journal of Gynecological Cancer 27:16–41.
   Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. 1987. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 60:2035–2041.
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. 2000. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Postoperative radiation therapy in endometrial carcinoma. The Lancet 355:1404–1411.
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, et al. 2004. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. Journal of Clinical Oncology 22:1234–1241.
   PubMed Web of Science ®Google Scholar
• Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. 2004. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecologic Oncology 92:744–751.
   PubMed Web of Science ®Google Scholar
• Kim HS, Suh DH, Kim MK, Chung HH, Park NH, Song YS. 2012. Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis. Japanese Journal of Clinical Oncology 42:405–412.
   PubMed Web of Science ®Google Scholar
• Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, et al. 2014. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American society for radiation oncology evidence-based guideline. Practical Radiation Oncology 4:137–144.
   PubMedGoogle Scholar
• Kong A, Johnson N, Kitchener HC, Lawrie TA. 2012. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. JNCI Journal of the National Cancer Institute 104:1625–1634.
   PubMedGoogle Scholar
• Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK. 2006. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 295:389–397.
   PubMed Web of Science ®Google Scholar
• Meyer LA, Bohlke K, Powell MA, Fader AN, Franklin GE, Lee LJ, et al. 2015. Postoperative radiation therapy for endometrial cancer: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology evidence-based guideline. Journal of Clinical Oncology 33:2908–2913.
   PubMed Web of Science ®Google Scholar
• Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, et al. 2010. Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan society of gynecologic oncology (JSGO) 2009 edition. International Journal of Clinical Oncology 15:531–542.
   PubMed Web of Science ®Google Scholar
• Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. 2010. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. The Lancet 375:816–823.
   PubMed Web of Science ®Google Scholar
• Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, et al. 2017. Call for surgical nodal staging in women with ESMO/ESGO/ESTRO high-intermediate risk endometrial cancer: a multicentre cohort analysis from the FRANCOGYN study group. Annals of Surgical Oncology 24:1660–1666.
   PubMed Web of Science ®Google Scholar
• Pecorelli S. 2009. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 105:103–104.
   PubMed Web of Science ®Google Scholar
• Sasada S, Yunokawa M, Takehara Y, Ishikawa M, Ikeda S, Kato T, et al. 2018. Baseline risk of recurrence in stage I-II endometrial carcinoma. Journal of Gynecologic Oncology 29:e9.
   PubMed Web of Science ®Google Scholar
• Schink JC, Rademaker AW, Miller DS, Lurain JR. 1991. Tumor size in endometrial cancer. Cancer 67:2791–2794.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2018. Cancer statistics, 2018. CA: A Cancer Journal for Clinicians 68:7–30.
   PubMed Web of Science ®Google Scholar
• Small W, Jr, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, et al. 2008. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology, Biology, Physics 71:428–434.
   PubMed Web of Science ®Google Scholar
• Wortman BG, Bosse T, Nout RA, Lutgens L, van der Steen-Banasik EM, Westerveld H, et al. 2018. Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial. Gynecologic Oncology 151:69–75.
   PubMed Web of Science ®Google Scholar